Corcept 制药 CORT
$72.77 +$1.14 (+1.59%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $72.77 0.00%
开盘$73.60
昨收$71.63
当日区间$72.17 – $74.86
成交量1.41M
市值$7.96B
市盈率（TTM）54.7
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例76.7%+0.07 个百分点，较上季度
持仓机构数496+13 ，较上季度
内部人近期交易10次买入 / 35次卖出净卖出
空头持仓比例7.95% 占流通股回补天数 12.3 · 截至 15 Oct 2026
卖空成交量占比14.3%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$14.07M（5个净流入日，15个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有33.5%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从9.08%降至7.95%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +182,570 | 0.2% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +2,159,774 | 2.4% |
| Emerald Advisers, LLC | Mutual Fund | 2026/Q3 | +828,062 | 1.1% |
| Fuller & Thaler Asset Management, Inc. | Mutual Fund | 2026/Q3 | +710,106 | 0.7% |
| Jacobs Levy Equity Management Inc | Mutual Fund | 2026/Q3 | +695,532 | 0.6% |
| Perceptive Advisors LLC | VC/PE Fund | 2026/Q3 | +348,385 | 0.4% |
| Ingalls & Snyder, LLC | Mutual Fund | 2026/Q3 | +325,791 | 7.3% |
| Allspring Global Investments, LLC | Mutual Fund | 2026/Q3 | +308,620 | 0.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +280,747 | 11.5% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +224,070 | 4.7% |
| Teachers Insurance and Annuity Association-College Retirement Equities Fund | Mutual Fund | 2026/Q3 | +176,123 | 0.3% |
| Bank of America Corporation | Public Company | 2026/Q3 | +174,772 | 0.3% |
| Granite Investment Partners, LLC | Mutual Fund | 2026/Q3 | +172,228 | 0.2% |
| Russell Investment Management, LLC | Mutual Fund | 2026/Q3 | +165,039 | 0.2% |
| FMR | Mutual Fund | 2026/Q3 | +147,261 | 3.1% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 14 Oct 2026 | James Wilson | Independent Chairperson | Automatic Disposition | -10,000 | $116.30 | 1,454,543 |
| 1 Oct 2026 | Roberto Vieira | President of Oncology | Derivative Exercise and Sale | -8,333 | $116.59 | 3,946 |
| 1 Oct 2026 | Sean Maduck | Former President of Endocrinology | Derivative Exercise and Sale | -25,000 | $116.55 | 119,655 |
| 1 Oct 2026 | Joseph Lyon | Chief Technology & Accounting Officer | Derivative Exercise and Sale | -10,000 | $116.54 | 5,683 |
| 30 Sep 2026 | Joseph Lyon | Chief Technology & Accounting Officer | Intent to Sell (Form 144) | -10,000 | $115.23 | – |
| 30 Sep 2026 | Justin Gunn | President of Endocrinology | Other Derivative Acquisition | +100,000 | $114.03 | 100,000 |
| 30 Sep 2026 | Justin Gunn | President of Endocrinology | Initial Statement of Beneficial | +0 | – | 6,965 |
| 23 Sep 2026 | Gary Robb | Chief Business Officer & Secretary | Other Acquisition | +10,000 | – | 94,914 |
| 23 Sep 2026 | Gary Robb | Chief Business Officer & Secretary | Other Disposition | -17,100 | – | 94,914 |
| 16 Sep 2026 | Gary Robb | Chief Business Officer & Secretary | Derivative Exercise and Retained | +17,493 | $8.27 | 102,014 |
| 15 Sep 2026 | Roberto Vieira | President of Oncology | Automatic Disposition | -296 | $100.82 | 3,946 |
| 14 Sep 2026 | James Wilson | Independent Chairperson | Automatic Disposition | -10,000 | $111.70 | 1,464,543 |
| 13 Sep 2026 | Joseph Lyon | Chief Technology & Accounting Officer | Derivative Exercise and Sale | -10,000 | $114.12 | 5,683 |
| 1 Sep 2026 | Atabak Mokari | Chief Financial Officer | Sale to Issuer | -102 | $113.38 | 16,304 |
| 1 Sep 2026 | Gary Robb | Chief Business Officer & Secretary | Sale to Issuer | -91 | $113.38 | 84,521 |
| 1 Sep 2026 | Sean Maduck | Former President of Endocrinology | Sale to Issuer | -117 | $113.38 | 119,655 |
| 1 Sep 2026 | Joseph Lyon | Chief Technology & Accounting Officer | Sale to Issuer | -72 | $113.38 | 5,683 |
| 1 Sep 2026 | Roberto Vieira | President of Oncology | Sale to Issuer | -102 | $113.38 | 4,242 |
| 1 Sep 2026 | Roberto Vieira | President of Oncology | Derivative Exercise and Sale | -58,333 | $115.44 | 4,242 |
| 31 Aug 2026 | Atabak Mokari | Chief Financial Officer | Other Acquisition | +276 | $113.38 | 16,304 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 8,588,418 | 7.9% | 12.3 |
| 30 Sep 2026 | 8,540,393 | 7.9% | 3.6 |
| 15 Sep 2026 | 9,350,914 | 8.7% | 9.9 |
| 31 Aug 2026 | 9,399,154 | 8.7% | 11.9 |
| 14 Aug 2026 | 9,696,757 | 9.0% | 10.5 |
| 31 Jul 2026 | 9,819,732 | 9.1% | 6.4 |
暂无评论——快来第一个聊聊 CORT。